Korea Stocks, page 9 of 36 — 24 articles published 2026-09-02 ~ 2026-09-04.
Infac (KRX: 023810) 2026 stock outlook. A deep look at the control-cable core business supplying Hyundai and Kia, the mechatronics shift into electronic parking brakes (EPB), hydrogen and electrification parts, and the automaker dependence and currency sensitivity that drive this Korean small-cap.
Macquarie Korea Infrastructure Fund (MKIF, KOSPI 088980) 2026 outlook: how toll roads, tunnels and ports generate distributions, why the price is rate-sensitive, concession-expiry and asset-recycling risk, and how foreign investors handle Korean dividend withholding and FX.
SK REIT (395400) 2026 outlook analyzing its quarterly-dividend structure, the SK Seorin office tower, gas-station sale-and-leaseback and data-center assets, the SK sponsor acquisition pipeline, interest-rate sensitivity, and refinancing and equity-dilution risk for US investors.
Sunjin (KOSPI 136490) 2026 stock outlook for US-based investors. How feed, hog farming, and meat processing chain together, why the corn-to-pork spread drives earnings, the Sunjin Pork processing arm, whether a low-PBR livestock re-rating can happen, plus ASF and feed-grain risk explained in plain English.
HLB Life Science (067630) 2026 stock outlook. An honest, qualitative breakdown of the HLB Group rivoceranib anticancer FDA re-filing narrative, what it means to be a value-chain proxy rather than the lead applicant, the group cross-shareholding and dilution risk, and why this is a binary event-driven biotech, not a fundamentals story.
Mirae Semiconductor (254490) 2026 stock outlook. A qualitative deep dive into its role as an official Samsung memory and system-chip distributor, the world's only Samsung memory AS center, the AI-memory demand leverage, and the thin-margin distribution reality of receivables and inventory risk.
Nextchip (KOSDAQ 396270) 2026 stock outlook. A qualitative deep dive into the automotive ADAS image-processor fabless: the Apache ISP and SoC roadmap, why rising camera counts drive the story, the fabless model's trade-offs, competition with Ambarella and Mobileye, and what US investors should watch on tax and FX.
Jahwa Electronics (033240) 2026 stock outlook. A deep qualitative look at the smartphone camera OIS/AF actuator cash cow, the pivot from ferrite magnetics into EV traction motors, heavy Samsung customer concentration, the competitive map, and what US investors should watch.
Kumyang (KOSPI 001570) 2026 stock outlook. A qualitative read on a mature blowing-agent cash cow stacking cylindrical-battery, lithium-mining and hydrogen ventures on top, plus the dilution risk from rights issues and convertibles, the theme-stock volatility, and how it compares with SDI, Panasonic and Korean battery peers for a US investor.
JVM Co. (054950) 2026 stock outlook. A qualitative deep dive into the ATDPS automated dispensing niche, razor-and-blade consumables economics, the Hanmi Science affiliation, European and US export growth, and the customer-concentration, FX, and slow-growth risks that define this Korean med-tech name.
Youlchon Chemical (008730) stock outlook 2026: stable Nongshim-affiliate flexible packaging demand, resin and aluminum cost-spread margin mechanics, limited growth ceiling, the EV battery pouch film option versus Japan's DNP and Resonac, dividend appeal and the value-trap risk. A qualitative deep dive for global investors.
Hanil Hyundai Cement (formerly Hyundai Cement, KRX 006390) 2026 stock outlook. A qualitative deep dive into its domestic cement business inside the Hanil Cement group, construction-cycle shipment demand, coal and power cost spreads, waste-fuel substitution, dividend appeal, and the risks foreign investors should weigh.
EcoPro Materials (450080) stock outlook for 2026. A qualitative deep dive on high-nickel precursor localization, the IRA and FEOC tailwind, EcoPro's vertically integrated battery value chain, the EV demand chasm, Chinese low-cost precursor competition, and affiliate governance risk.
Green Cross Holdings (005250) 2026 stock outlook. A deep, qualitative read on the Korean pharma holding company behind blood-plasma and vaccine maker GC Biopharma, its NAV discount, dividend appeal, governance, and how it differs from operating subsidiary 006280.
Cosmax BTI (044820) 2026 stock outlook. A deep look at the Cosmax Group holding company: how its stake in listed operating unit Cosmax (192820) and health-supplement maker Cosmax NBT drives net-asset value, why holdco discounts persist, dividend flow, dual-listing risk, and how it differs from the operating company itself.
Wemade Max (101730) 2026 stock outlook. A KOSDAQ game publisher and Wemade subsidiary levered to its parent's new titles, the Mir IP franchise, and the WEMIX blockchain platform — with a deep look at earnings volatility, parent risk, and small-cap liquidity.
Philoptics (161580) 2026 stock outlook. A deep qualitative look at three growth legs — display laser cutting, EV battery notching, and glass substrate (TGV) equipment — plus the equipment-vendor earnings swings, Samsung customer concentration, and capex-cycle leverage that define the stock.
DMS (Digital Manufacturing System, 068790) 2026 stock outlook. A deep qualitative look at its display and semiconductor wet-process equipment business, dependence on Chinese panel capex, the LCD-to-OLED transition, and its push to diversify into solar and battery equipment.
GST Global Standard Technology (KOSDAQ 083450) stock outlook for 2026. A deep look at the moat of a Korean niche supplier that builds both semiconductor process chillers and gas scrubbers, its sensitivity to front-end capex cycles, the environmental-regulation tailwind, and the customer-concentration and small-cap volatility risks.
Sajo Seafood (KOSPI 014710) 2026 stock outlook. A deep qualitative read on its place inside Sajo Group's vertical integration, the tuna cost cycle driven by skipjack prices, bunker fuel and the won-dollar rate, domestic seafood demand, and the asset-value-versus-governance discount.
Innowireless (KOSDAQ 073490) 2026 stock outlook. A deep qualitative look at its 5G wireless test-and-measurement moat, small-cell and positioning businesses, the telecom capex cycle, the 6G catalyst, overseas-operator demand swings, and the risks of owning a small-cap cyclical.
Samil Pharmaceutical (KOSPI 000520) 2026 stock outlook. A deep qualitative look at the Korean ophthalmic eye-drop franchise, the large sterile-ophthalmic CDMO plant in India, the operating leverage tied to plant utilization, the upfront capital burden, and what US investors should watch on tax and currency.
Dasan Networks (KOSDAQ 039560) 2026 stock outlook. A deep qualitative look at its switch and PON fiber-access hardware business, US and Japan export exposure, currency leverage, dependence on carrier capex cycles, the DZS (former Dasan Zhone) relationship risk, and how it stacks up against Korean peers.
Taewoong Logistics (KOSDAQ 124560) stock outlook for 2026. A deep qualitative look at the asset-light freight-forwarding model, its Central Asia and CIS route moat, exposure to SCFI freight rates and global trade volume, roll-up M&A growth, and what US investors should weigh on currency and foreign-dividend tax.